Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,562 | -10,300 | -5,177 | -32,834 | -26,032 |
| Depreciation Amortization | 37 | 21 | 10 | 31 | 22 |
| Accounts payable and accrued liabilities | 222 | -144 | -250 | 258 | 1,485 |
| Other Working Capital | -1,132 | 593 | -211 | 388 | 2,123 |
| Other Operating Activity | 1,566 | 1,344 | 1,033 | 3,831 | 1,817 |
| Operating Cash Flow | $-13,869 | $-8,486 | $-4,595 | $-28,326 | $-20,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,015 | -13,000 | -18,000 | 8,486 | 1,284 |
| PPE Investments | -92 | -36 | -12 | -79 | -80 |
| Sale Of Investment | -146 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,253 | $-13,036 | $-18,012 | $8,407 | $1,204 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,903 | 27,903 | 27,903 | N/A | N/A |
| Other Financing Activity | 13 | 13 | 0 | 0 | 0 |
| Financing Cash Flow | $27,916 | $27,916 | $27,903 | $N/A | $N/A |
| Beginning Cash Position | 2,176 | 2,176 | 2,176 | 22,095 | 22,095 |
| End Cash Position | 9,970 | 8,570 | 7,472 | 2,176 | 2,714 |
| Net Cash Flow | $7,794 | $6,394 | $5,296 | $-19,919 | $-19,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,869 | -8,486 | -4,595 | -28,326 | -20,585 |
| Capital Expenditure | -92 | -36 | -12 | -79 | -80 |
| Free Cash Flow | -13,961 | -8,522 | -4,607 | -28,405 | -20,665 |